Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,084 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consequences of a telomerase-related fitness defect and chromosome substitution technology in yeast synIX strains.
McCulloch LH, Sambasivam V, Hughes AL, Annaluru N, Ramalingam S, Fanfani V, Lobzaev E, Mitchell LA, Cai J; Build-A-Genome Class; Jiang H, LaCava J, Taylor MS, Bishai WR, Stracquadanio G, Steinmetz LM, Bader JS, Zhang W, Boeke JD, Chandrasegaran S. McCulloch LH, et al. Among authors: ramalingam s. Cell Genom. 2023 Nov 9;3(11):100419. doi: 10.1016/j.xgen.2023.100419. eCollection 2023 Nov 8. Cell Genom. 2023. PMID: 38020974 Free PMC article.
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC.
Lu S, Kato T, Dong X, Ahn MJ, Quang LV, Soparattanapaisarn N, Inoue T, Wang CL, Huang M, Yang JC, Cobo M, Özgüroğlu M, Casarini I, Khiem DV, Sriuranpong V, Cronemberger E, Takahashi T, Runglodvatana Y, Chen M, Huang X, Grainger E, Ghiorghiu D, van der Gronde T, Ramalingam SS; LAURA Trial Investigators. Lu S, et al. Among authors: ramalingam ss. N Engl J Med. 2024 Jun 2. doi: 10.1056/NEJMoa2402614. Online ahead of print. N Engl J Med. 2024. PMID: 38828946
Natural History and Real-World Treatment Outcomes for Patients With NSCLC Having EGFR Exon 20 Insertion Mutation: An International Association for the Study of Lung Cancer-American Society of Clinical Oncology CancerLinQ Study.
Behera M, Jiang R, Huang Z, Bunn B, Wynes MW, Switchenko J, Scagliotti GV, Belani CP, Ramalingam SS. Behera M, et al. Among authors: ramalingam ss. JTO Clin Res Rep. 2023 Oct 19;5(6):100592. doi: 10.1016/j.jtocrr.2023.100592. eCollection 2024 Jun. JTO Clin Res Rep. 2023. PMID: 38827378 Free PMC article.
Targeting PfProhibitin 2-Hu-Hsp70A1A complex as a unique approach towards malaria vaccine development.
Marothia M, Behl A, Maurya P, Saini M, Shoaib R, Garg S, Kumari G, Biswas S, Munjal A, Anand S, Kahlon AK, Gupta P, Biswas S, Goswami B, Abdulhameed Almuqdadi HT, Bhowmick IP, Shevtsov M, Ramalingam S, Ranganathan A, Singh S. Marothia M, et al. Among authors: ramalingam s. iScience. 2024 May 7;27(6):109918. doi: 10.1016/j.isci.2024.109918. eCollection 2024 Jun 21. iScience. 2024. PMID: 38812541 Free PMC article.
The United Kingdom's First Cardio-Oncology Service: A Decade of Growth and Evolution.
Andres MS, Murphy T, Poku N, Nazir MS, Ramalingam S, Baksi J, Jarman JWE, Khattar R, Sharma R, Rosen SD, Lyon AR. Andres MS, et al. Among authors: ramalingam s. JACC CardioOncol. 2024 Feb 6;6(2):310-312. doi: 10.1016/j.jaccao.2023.12.003. eCollection 2024 Apr. JACC CardioOncol. 2024. PMID: 38774020 Free PMC article. No abstract available.
1,084 results